Neochem Bio SME: Check IPO Date, Live Subscription and Key Details
Neo Chem Bio Solution is a specialty performance chemical company with over 40 years of experience, making more than 350 customized chemical formulations. Its products are used in textiles, garment washing, home & personal care (HPC), industrial cleaning, water treatment, paints, and construction. The company operates an integrated manufacturing facility in Sanand, Ahmedabad, with an installed capacity of 22,000 MTPA, supported by an in-house R&D lab and multiple global certifications including ZDHC Level 3 and GOTS 7.0.
Price Range
₹93.0 - ₹98.0
Issue Size
₹42.69 Cr
Lot Size
1,200 shares
IPO Type
NSE SME
GMP
₹2(+2.04%)
Est. Listing Price
₹100
Estimate Profit
₹4,800
Retail Portion
33.26%
Key Metrics
Check Live GMPGMPFace Value
₹10
EPS
6.41
P/E Ratio
15.3
RoNW
48.82%
ROE
48.82%
Debt to Equity
1.8
Advertisement
Timeline
IPO Opens
2 Dec
IPO Closes
4 Dec
Allotment
5 Dec
Listing
9 Dec
IPO Timeline & Listing Details
| Event | Date | Details |
|---|---|---|
| IPO Open Date | 2 December 2025 | Subscription starts |
| IPO Close Date | 4 December 2025 | Subscription ends |
| Allotment Date | 5 December 2025 | Allotment |
| Listing Date | 9 December 2025 | Listing |
Investment Categories
| Category | Lots | Amount |
|---|---|---|
Individual | 2 | ₹2,35,200 |
SHNI (Min) | 3 | ₹3,52,800 |
SHNI (Max) | 8 | ₹9,40,800 |
BHNIAbove ₹10,00,000 | 9 | ₹10,58,400 |
IPO Reservation Details
| Category | Reservation |
|---|---|
| QIB (Qualified Institutional Buyer) | 47.38% |
| NII (Non-Institutional Investor) | 14.28% |
| SHNI (Small Non-Institutional Investor) | 4.76% |
| BHNI (Big Non-Institutional Investor) | 9.52% |
| Retail | 33.26% |
| Market Maker | 5.07% |
| Total | 100.00% |
IPO Objectives
- Funding the long-term working capital requirements of the Company (₹23.90 Cr).
- Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by the Company (₹10.00 Cr).
- General Corporate Purposes.
Strengths
- The company has integrated and flexible manufacturing operations in Sanand, Ahmedabad, supporting both liquid and powder formulations with 22,000 MTPA capacity.
- It possesses a strong understanding of applied chemistries for diverse end-use industries (textiles, HPC, water treatment), serving over 350 customers globally.
- The business is backed by research and development (R&D) capabilities with an in-house lab dedicated to developing performance chemistries.
- It holds multiple global certifications (ISO 9001, ZDHC Level 3, GOTS 7.0), ensuring high compliance in sustainability and quality.
- The company shows strong financial growth, with Revenue increasing by 39% and profit after tax (PAT) surging by 330% between FY24 and FY25.
Weaknesses
- The company has a High Debt-to-Equity ratio of 1.80 in FY25, indicating significant financial leverage.
- Operations are working capital intensive, with the largest portion of the Fresh Issue allocated to funding long-term working capital needs.
- It is vulnerable to raw material price volatility (Polymers, Surfactants, Esters) and is dependent on the performance of cyclical end-use industries like textiles.
- The significant spike in PAT (330% in FY25) raises questions about its sustainability and may not be representative of long-term organic growth.
Advertisement
Financial Performance
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets (₹ Cr.) | 96.49 | 78.89 | 64.06 | 50.6 |
| Revenue (₹ Cr.) | 47.18 | 86.15 | 62.01 | 48.79 |
| PAT (₹ Cr.) | 5.48 | 7.75 | 1.8 | 1.07 |
| Net Worth (₹ Cr.) | 32.24 | 19.75 | 12 | 8.05 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|---|---|---|---|
| Neochem Bio Solutions | 5.8 | 15.3 | 48.82% | 32.24 |
| Rossari Biotech | 2.68 | 24.53 | 10.92% | 1,185 |
Subscription Details
Daily Bids Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 1x | 1.23x | 21.97x |
| NII | 1.1x | 2x | 21.15x |
| S-HNI | 0.3x | 0.86x | 11.88x |
| B-HNI | 1.49x | 2.57x | 25.78x |
| RII | 0.5x | 1.02x | 9.42x |
| Total | 0.77x | 1.29x | 15.52x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 8,71,200 | 1,91,42,400 | 187.6 |
| NII | 6,55,200 | 1,38,55,200 | 135.78 |
| Small NII | 2,18,400 | 25,94,400 | 25.43 |
| Big NII | 4,36,800 | 1,12,60,800 | 110.36 |
| RII | 15,26,400 | 1,43,76,000 | 140.88 |
| Total | 30,52,800 | 4,73,73,600 | 464.26 |
Advertisement
Company Details
- Neochem Bio Solutions Ltd.
- 303, W1, Opp. Vikramnagar Colony, Off. Iscon- Ambli Road, Ahmedabad, -380058
- +91 079 35217792
- compliance@neochem.in
- http://www.neochem.in/
Registrar Details
- MUFG Intime India Pvt.Ltd.
- +91-22-4918 6270
- neochem.smeipo@in.mpms.mufg.com
- https://linkintime.co.in/Initial_Offer/public-issues.html
Frequently Asked Questions
What are the core products manufactured by Neochem Bio Solutions?
Neochem Bio manufactures over 350 customized formulations under four segments: Polymers, Surfactants, Silicones, and Esters/Bio-based Solutions. These are specialty performance chemicals for textiles, HPC, water treatment, and paints.
When will the Neochem Bio IPO open and close?
The Neochem Bio SME IPO opens for subscription on December 2, 2025, and closes on December 4, 2025.
What is the IPO price band and tentative listing date?
The price band is ₹93.00 to ₹98.00 per share, and the tentative listing date on the NSE SME is December 9, 2025.
What are the main objectives for the ₹42.69 Cr Fresh Issue?
The net proceeds are primarily for funding the long-term working capital requirements (₹23.90 Cr) and repayment of outstanding borrowings (₹10.00 Cr).
What are the key financial strengths of Neochem Bio?
The company reported a massive 330% rise in PAT in FY25 (₹7.75 Cr) on a revenue of ₹86.15 Cr, supported by strong growth and a high RoNW of 39.24%.
What quality certifications does Neochem Bio hold?
The company holds multiple global certifications including ISO 9001:2015, ISO 14001, ZDHC Level 3, and GOTS 7.0, ensuring compliance in sustainability and quality.
Loading comments...